Strategic Intelligence Report
Generated July 29, 2026
Artificial Intelligence
EvolutionaryScale
Strategic importance is our editorial rating of how central this entity is to the technology landscape we track; confidence reflects how well-sourced and current the underlying evidence is.
1
Chokepoint Score
1 other entity structurally depend on this one
Headquarters
New York, New York, USA
Website
Employees
40 (2026, approximate)
Founded
2024
Listing
private
Overview
A protein-design foundation model company founded by former Meta AI researchers, positioned as a horizontal, OpenAI-for-proteins platform rather than an applied biologics or optimization tool. EvolutionaryScale raised $142 million in a single seed round in June 2024 -- by far the largest seed financing on record in synthetic biology -- and released the open weights and code for ESM3, its flagship protein language model, alongside a freely available AI-generated fluorescent protein sequence.
Dependency Map
One hop in each direction — see Strategic Connections below for the full, sourced breakdown of every relationship.
Strategic Connections
Development
- AI Protein Design & Synthetic Biology: EvolutionaryScale develops ESM3, an open-weight protein language model positioned as a horizontal foundation-model platform for biology.
- Meta: EvolutionaryScale was founded by former Meta AI researchers who previously worked on protein language models at Meta.
Competition / Other
- Earendil Labs: EvolutionaryScale competes with Earendil Labs, though EvolutionaryScale pursues a horizontal foundation-model approach versus Earendil's applied antibody/biologics programs.
- Cradle: EvolutionaryScale competes with Cradle in AI protein design, though EvolutionaryScale's foundation-model approach differs from Cradle's optimization-platform model for existing R&D teams.
Strategic Risks
- Horizontal foundation-model strategy requires broad ecosystem adoption to monetize versus applied competitors' direct pharma revenue
- Open-weight release strategy could commoditize its own core technology advantage
Future Outlook
- Continued development of ESM-family protein language models as a foundation layer for the broader AI protein design ecosystem
- Potential for downstream commercial products built on top of its open-weight research releases
Sources
- C&EN (Chemical & Engineering News) (Jun 2024) — EvolutionaryScale launches with record $142M seed, releases ESM3 open weights
Generated by InsightNodes — Technology Intelligence Platform. This report reflects sourced, evidence-backed information as of the dates cited above and is not investment advice.
Viewing the Full Analyst Report — switch to the Executive Summary.